Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02495545 · ClinicalTrials.gov registry record · NA

Cerebrospinal Fluid Drainage (CSFD) in Acute Spinal Cord Injury

A NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02495545: Completed NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.

NCT02495545 is a NA study that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02495545, a NA study, has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this Phase IIB randomized controlled trial is to evaluate the safety and efficacy of CSFD and to provide a preliminary clinical efficacy evaluation of the combination of CSFD and elevation of mean arterial pressure (MAP) in patients with acute spinal cord injury (SCI). The objectives of the trial are to evaluate (i) efficacy of reducing intrathecal pressure (ITP) by CSFD in patients with acute SCI; (ii) preliminary efficacy of combination of CSFD and elevation of MAP compared to elevation of MAP alone in improving neurologic motor outcomes in patients with acute SCI; and, (iii) safety of intensive CSFD in acute SCI patients.

Primary Outcome

ITP will be measured in both groups every hour for the duration of study treatment for a total of 121 measurements consisting of one pre-treatment measurement (time 0 hours) and 120 measurements during the treatment (time 1-120 hours).

Interventions

  • PROCEDURE CSFD and elevation of MAP
  • PROCEDURE Maintenance of MAP

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2015-10
Est. Completion 2019-10-25
Phase NA

What the finished NCT02495545 record still lists

NCT02495545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which CSFD and elevation of MAP is the first listed.

NCT02495545 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02495545 about?

NCT02495545 is a clinical study titled "Cerebrospinal Fluid Drainage (CSFD) in Acute Spinal Cord Injury". The purpose of this Phase IIB randomized controlled trial is to evaluate the safety and efficacy of CSFD and to provide a preliminary clinical efficacy evaluation of the combination of CSFD and elevation of mean arterial pressure (MAP) in patients with acute spinal cord injury (SCI). The objectives ...

What is the current status of trial NCT02495545?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-10. Estimated completion is 2019-10-25.

What interventions are being tested in trial NCT02495545?

The interventions under investigation include: CSFD and elevation of MAP (PROCEDURE), Maintenance of MAP (PROCEDURE).

Who is sponsoring clinical trial NCT02495545?

This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02495545's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02495545, the US trial registry maintained by the National Library of Medicine. NCT02495545 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.